Ruifen Sun | Drug Discovery and Development | Women Researcher Award

Published on by Top Pharmaceutical

Prof. Ruifen Sun | Drug Discovery and Development | Women Researcher Award

Yunnan University of Chinese Medicine | China

Prof. Ruifen Sun is a nationally recognized academic leader, medical doctor, and senior nursing scholar whose work has made a significant impact on integrated traditional Chinese and Western medicine, particularly in the prevention and treatment of tumors and other major diseases. She serves as Professor, Doctoral Supervisor, and Postdoctoral Supervisor, and is widely acknowledged as a national-level first-class professional leader in nursing education. Prof. Sun is the Head of the Master’s Program in Nursing and leads Yunnan Province’s first-class discipline of Integrated Traditional Chinese and Western Medicine Nursing, where she has played a pivotal role in shaping disciplinary development, curriculum innovation, and high-level talent cultivation.With an extensive research portfolio, Prof. Sun has published more than forty SCI-indexed papers and holds both an authorized invention patent and an authorized utility model patent, reflecting her strong capacity for scientific innovation and translational research. She has led numerous nationally and provincially funded research projects, teams, and academic platforms, including major initiatives supported by the National Natural Science Foundation of China. Her research integrates theoretical exploration with clinical application, bridging traditional Chinese medicine nursing practices and modern biomedical approaches.Prof. Sun is an active participant in the global academic community, having delivered oral presentations and engaged in scholarly exchanges at leading international conferences across Europe and North America. She has also served as a state-sponsored visiting scholar at a major medical center in the United States, further strengthening her international academic vision. Beyond academia, she is a member of the National Traditional Chinese Medicine Standards Advisory Expert Database and a distinguished young talent under Yunnan Province’s high-level talent program. She has additionally contributed to regional governance through public service leadership roles. Currently, she serves as Dean of the School of Nursing at Yunnan University of Traditional Chinese Medicine and leads its Overseas Students Association, continuing to influence nursing education, research excellence, and international collaboration.

Citation Metrics (Scopus)

900

700

500

300

100

0

Citations
884

Documents
46

h-index
19

Citations
Documents
h-index


View Scopus Profile View Google Scholar Profile View ORCID Profile

Featured Publications

Ruby Anto | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Ruby Anto | Drug Discovery and Development | Best Researcher Award

Centre of Excellence in Nutraceuticals | India

Dr. Ruby Anto is a distinguished biochemist and cancer researcher with an extensive career dedicated to advancing the fields of molecular oncology, bioimmunotherapy, and nutraceutical science. She currently serves as Chief Scientist at the Centre of Excellence in Nutraceuticals, KSCSTE, Government of Kerala, Thiruvananthapuram, and Honorary Scientist at the Institute of Advanced Virology, Thiruvananthapuram. Over her accomplished career, she has held numerous scientific positions at the Rajiv Gandhi Centre for Biotechnology, progressing from Research Associate to Scientist G, reflecting her consistent contributions and leadership in biomedical research.Dr. Anto earned her PhD in Biochemistry from Amala Cancer Research Centre, Thrissur, following her postgraduate studies in Chemistry and Education. Her multidisciplinary academic background—combining chemistry, biochemistry, and pedagogy—has been central to her innovative approach to cancer biology and molecular medicine. Her early academic achievements and later professional experiences at prestigious institutions such as the M.D. Anderson Cancer Center, Houston, provided a strong foundation for her research on targeted cancer therapies, chemopreventive agents, and the role of natural products in disease modulation.Recognized nationally and internationally for her scientific excellence, Dr. Anto has received several prestigious honors, including the Young National Women Bio-Scientist Award from the Department of Biotechnology, Government of India, and fellowships from the National Academy of Sciences, India, and the Academy of Sciences, Thiruvananthapuram. Her professional journey also includes global training experiences, such as her participation in the Clinical Trials Traineeship Program at INSERM, Paris, which broadened her expertise in translational research and clinical validation of nutraceutical interventions.As a mentor, Dr. Anto has nurtured a generation of young scientists, with her students and postdoctoral fellows earning numerous national and international awards for their work in cancer biology and nutraceutical research. Her leadership has fostered a thriving academic environment focused on the discovery and characterization of bioactive compounds from natural sources with therapeutic potential.Dr. Anto’s scientific publications have advanced understanding in areas such as natural compound-mediated cancer prevention, signaling pathway modulation, and anti-inflammatory mechanisms of nutraceuticals. Through her research, she continues to bridge the gap between basic biochemistry and applied health sciences, promoting nutraceutical innovation as a cornerstone of preventive and personalized medicine. Her lifelong dedication to scientific inquiry and mentorship underscores her status as one of India’s leading voices in biochemistry and nutraceutical research.

Profile: Google Scholar

Featured Publications

Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., & Kuttan, R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Letters, 94(1), 79–83.

Anto, R. J., Mukhopadhyay, A., Denning, K., & Aggarwal, B. B. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis, 23(1), 143–150.

Anto, R. J., Sukumaran, K., Kuttan, G., Rao, M. N. A., Subbaraju, V., & Kuttan, R. (1995). Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Letters, 97(1), 33–37.

Oommen, S., Anto, R. J., Srinivas, G., & Karunagaran, D. (2004). Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells. European Journal of Pharmacology, 485(1–3), 97–103.*

Anto, R. J., Mukhopadhyay, A., Shishodia, S., Gairola, C. G., & Aggarwal, B. B. (2002). Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: Correlation with induction of cyclooxygenase-2. Carcinogenesis, 23(9), 1511–1518.*

Bava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D., & Anto, R. J. (2005). Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κB and the serine/threonine kinase Akt and is independent of tubulin polymerization. Journal of Biological Chemistry, 280(8), 6301–6308.*

Srinivas, G., Anto, R. J., Srinivas, P., Vidhyalakshmi, S., Senan, V. P., & Karunagaran, D. (2003). Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. European Journal of Pharmacology, 473(2–3), 117–125.*